Famotidine Powder, For Suspension
Product Images NDC 51407-452

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 51407-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-452-50ol.jpg (51407 452 50ol)

Each 5 mL of Famotidine oral suspension when reconstituted as directed contains 40 mg of Famotidine. The package insert should be consulted for dosage information. The dry powder and suspension should be stored between 15°C to 30°C. The remaining text is not-available.*

FDA Label Image

Structure (Famotidine Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.